Company Filing History:
Years Active: 2002-2005
Title: Innovations by Eric M Mishkin
Introduction
Eric M Mishkin is an accomplished inventor based in Monroe, NY, with a focus on enhancing immune responses to herpes simplex virus (HSV). He holds two patents that reflect his significant contributions to the field of immunology.
Latest Patents
Mishkin's latest patents include a method for enhancing immune responses to herpes. This method involves immunization with a DNA vaccine composition that encodes the HSV type 1 or type 2 gD protein, along with interleukin-12 heterodimer subunits. The protocol also includes subsequent immunizations with a protein vaccine composition containing the gD protein and IL-12 heterodimer. The inclusion of a local anesthetic in the DNA vaccine composition enhances the immune response against HSV in mammals. Another notable patent pertains to an immunogenic composition of interleukin-12, alum, and herpes simplex viral antigen, which modulates the protective immune response to the antigen.
Career Highlights
Throughout his career, Eric M Mishkin has worked with prominent companies such as Wyeth and Wyeth Holdings Corporation. His work has significantly advanced the understanding and treatment of herpes simplex virus infections.
Collaborations
Mishkin has collaborated with notable individuals in his field, including John Hayward Eldridge and Robert J Natuk. Their combined expertise has contributed to the development of innovative vaccine compositions.
Conclusion
Eric M Mishkin's contributions to immunology, particularly in the area of herpes simplex virus, demonstrate his commitment to advancing medical science. His patents reflect a dedication to enhancing immune responses and improving therapeutic options for patients.